Minerva Neurosciences NERV
NASDAQ NERV
$3.35 -0.05 (-1.47%)
At close: Sep 29, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) EBT Margin (2020)

Updated

Minerva Neurosciences (NERV) reported EBT Margin of 4.71% for FY2020.

Analysis

Minerva Neurosciences (NERV) EBT Margin (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Minerva Neurosciences 160.57 Mn 160.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 71.72%
API Access

Minerva Neurosciences EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=NERV&period=max&api_key=YOUR_API_KEY